Observational studyBMC psychiatry2025
Sex differences in lithium concentrations among bipolar patients with different episodes based on real-world therapeutic monitoring data.
Observational study in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSex differences in lithium-associated efficacy and adverse events have been well studied in bipolar disorder. Exploring variations in lithium concentrations between sexes may offer potential explanations.
methodsThis multicenter, real-world, observational study, which was based on therapeutic monitoring data, was conducted at six Chinese hospitals. Sex differences in lithium concentrations and potential affecting factors were explored using the generalized estimating equation and multiple linear regression analysis, respectively.
resultsA total of 525 bipolar patients were included, comprising 328 patients diagnosed with mania or mania with depressive features and 197 with bipolar depression. There were 398 females and 127 males, including 79 patients aged 13-17 years. The median final lithium dosage of all the subjects was 0.9 g per day, with an average final concentration of 0.68 mmol/L. The lithium concentration was relatively stable in the context of a fixed dosage. In patients with mania or mixed features, lithium concentrations in females were significantly higher than those in males when a fixed lithium dosage was administered. This phenomenon was not observed in patients with bipolar depression. The number of factors influencing lithium concentrations was greater for males with mania or mixed features than for females, which was not observed between males and females with bipolar depression.
conclusionsThe therapeutic lithium concentrations of bipolar male and female patients in real-world clinical practice were lower than the guideline-recommended ranges. In patients with manic or mixed features, females have a greater propensity for lithium accumulation than males do, and lithium concentrations are more likely to be affected by internal and external changes in males than in females. Therefore, the potential risk of toxicity and the stability of lithium concentrations are key points in females and males on lithium therapy, respectively.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.